Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 89Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Dipharma Francis Srl

02 2Shandong New Time Pharmaceutical Co., Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for 16051-77-7 / Isosorbide Mononitrate API manufacturers, exporters & distributors?

Isosorbide Mononitrate manufacturers, exporters & distributors 1

26

PharmaCompass offers a list of Isosorbide Mononitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Isosorbide Mononitrate manufacturer or Isosorbide Mononitrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Isosorbide Mononitrate manufacturer or Isosorbide Mononitrate supplier.

PharmaCompass also assists you with knowing the Isosorbide Mononitrate API Price utilized in the formulation of products. Isosorbide Mononitrate API Price is not always fixed or binding as the Isosorbide Mononitrate Price is obtained through a variety of data sources. The Isosorbide Mononitrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Isosorbide Mononitrate

Synonyms

Isosorbide 5-mononitrate, 16051-77-7, Imdur, Corangin, Monosorbitrate, Monoket

Cas Number

16051-77-7

Unique Ingredient Identifier (UNII)

LX1OH63030

About Isosorbide Mononitrate

Isosorbide Mononitrate is the mononitrate salt form of isosorbide, an organic nitrate with vasodilator activity. Isosorbide mononitrate relaxes vascular smooth muscle by formation of the free radical nitric oxide (NO), which is identical to the endothelium-derived relaxing factor (EDRF). NO activates guanylyl cyclase, thereby increasing the synthesis of cGMP within smooth muscle, resulting in dephosphorylation of light chain myosin and relaxation of peripheral arteries and veins. In addition, isosorbide mononitrate relaxes coronary arteries, thereby increasing the blood circulation through the ischemic area. (NCI05)

Monoket Retard Manufacturers

A Monoket Retard manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Monoket Retard, including repackagers and relabelers. The FDA regulates Monoket Retard manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Monoket Retard API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Monoket Retard manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Monoket Retard Suppliers

A Monoket Retard supplier is an individual or a company that provides Monoket Retard active pharmaceutical ingredient (API) or Monoket Retard finished formulations upon request. The Monoket Retard suppliers may include Monoket Retard API manufacturers, exporters, distributors and traders.

click here to find a list of Monoket Retard suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Monoket Retard NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Monoket Retard as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Monoket Retard API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Monoket Retard as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Monoket Retard and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Monoket Retard NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Monoket Retard suppliers with NDC on PharmaCompass.

Monoket Retard Manufacturers | Traders | Suppliers

Monoket Retard Manufacturers, Traders, Suppliers 1
24

We have 2 companies offering Monoket Retard

Get in contact with the supplier of your choice:

  1. Dipharma
  2. Lunan Pharmaceutical
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.